tiprankstipranks
Roth MKM biotech analyst holds an analyst/industry conference call
PremiumThe FlyRoth MKM biotech analyst holds an analyst/industry conference call
16d ago
Intra-Cellular downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
Intra-Cellular downgraded to Neutral from Overweight at Piper Sandler
19d ago
Intra-Cellular downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Intra-Cellular downgraded to Market Perform from Outperform at Leerink
19d ago
Intra-Cellular downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyIntra-Cellular downgraded to Neutral from Overweight at Cantor Fitzgerald
19d ago
Intra-Cellular downgraded to Hold from Buy at Needham
Premium
The Fly
Intra-Cellular downgraded to Hold from Buy at Needham
19d ago
Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley
19d ago
Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash
PremiumThe FlyJohnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash
20d ago
Johnson & Johnson exploring bid for Intra-Cellular Therapies, Bloomberg reports
Premium
The Fly
Johnson & Johnson exploring bid for Intra-Cellular Therapies, Bloomberg reports
20d ago
Intra-Cellular price target raised to $118 from $100 at BofA
Premium
The Fly
Intra-Cellular price target raised to $118 from $100 at BofA
21d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100